Pregnancy and commonly used drugs in hematology practice.

Gideon Koren*, Michael Lishner

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


When a woman suffering from a hematological condition is contemplating pregnancy, she may need to continue the use of medications that do not have sufficient evidence of fetal safety. We discuss the evidence existing for some therapies of major hematological conditions in the context of major principles in clinical teratology. It is critical to always balance the potential fetal risks of the drug in question against the maternal and fetal risks of the untreated hematological condition.


Dive into the research topics of 'Pregnancy and commonly used drugs in hematology practice.'. Together they form a unique fingerprint.

Cite this